Detailansicht

Wissensnetz

Person

Petra Reinke

Ärztin

Name	Petra Reinke
Ort	Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Ärztin (charakteristischer Beruf)
Weitere Angaben	Nephrologin und Transplantations-Medizinerin; seit 2006 das Forschungsfeld Immunologie und die Reinraumherstellungsräume (GMP), Berlin-Brandenburger Centrum für Regenerative Therapien
Datensatztyp	Person
GND-Nummer	1165351692
Datensatz-ID	1165351692
Beteiligt an alle anzeigen A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation Kidney transplant monitoring by urinary flow cytometry: Biomarker combination of T cells, renal tubular epithelial cells, and podocalyxin-positive cells detects rejection Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation The role of pre-existing cross-reactive central memory CD4 T-cells in vaccination with previously unseen Influenza strains High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials BKV, CMV, and EBV interactions and their effect on graft function one year post-renal transplantation : : results from a large multi-centre study Differential T cell response against BK virus regulatory and structural antigens: a viral dynamics modelling approach Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Petra Reinke

A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation

BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach

Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells

Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation

Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation

Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients

Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients

Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment

Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment

Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study

The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation

Kidney transplant monitoring by urinary flow cytometry: Biomarker combination of T cells, renal tubular epithelial cells, and podocalyxin-positive cells detects rejection

Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients

The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation

A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation

A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation

The role of pre-existing cross-reactive central memory CD4 T-cells in vaccination with previously unseen Influenza strains

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials

BKV, CMV, and EBV interactions and their effect on graft function one year post-renal transplantation : : results from a large multi-centre study

Differential T cell response against BK virus regulatory and structural antigens: a viral dynamics modelling approach

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials

Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial